tiprankstipranks
Trending News
More News >

Novavax Covid vaccine unlikely to be approved soon, WSJ says

The Food and Drug Administration missed the deadline for making a decision regarding a Covid-19 vaccine from Novavax (NVAX), Liz Essley Whyte of Wall Street Journal reports. The FDA was set to give full approval to Novavax’s shot, but senior leaders at the agency are now sitting on the decision and have said Novavax’s application needed more data and was unlikely to be approved soon, people familiar with the matter told the Journal. The FDA has allowed emergency use of Novavax’s Covid-19 vaccine, but set an April 1 deadline for a decision on whether to grant a normal, full approval, the people said.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue